In the 90 days prior to the date of this filing, there have been 27 insider transactions reported to the SEC for Illumina. These transactions came from the activities of 13 different insiders that resulted in a net disposition of 21,626 company shares. Relative to the preceding 90-day window of time, there were 22 transactions from 8 insiders that resulted in the net disposition of 33,329 shares.
This level of insider transactions is lower than the peer group average in the 100-company Advanced Medical Equipment & Technology peer group over the last 90-day period. Peer group activity averaged 69.2 transactions per company, with company insiders acquiring on average 25,102 shares.
SEC Story Link http://www.sec.gov/Archives/edgar/data/1110803/000112760219026807/xslF345X03/form4.xml
|Consensus Estimates for Zynex's Q4, 2019, 2020 Years...|
|Alleghany's 2020, and Q1 Estimates Lowered but 2021 ...|
|Zscaler's 2021 Earnings Estimate Cut|
|Cimarex Energy's 2020, 2021, and Q1 Earnings Estimat...|
|Wynn Resorts' Consensus Forecasts for Q1, 2020, and ...|